Stockreport

Mersana Therapeutics stock leaps after FDA lifts hold on cancer therapy trial [MarketWatch]

Mersana Therapeutics, Inc.  (MRSN) 
Last mersana therapeutics, inc. earnings: 2/28 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: mersana.com/about-mersana
PDF UPDATE: Mersana Therapeutics stock leaps 4.7% after FDA lifts clinical hold on cancer therapy trial Mersana Therapeutics Inc. MRSN, +1.77% said Monday the U.S. Food a [Read more]